Home › Multiple Myeloma › Oklahoma
Multiple Myeloma clinical trials in Oklahoma
3 studies for Multiple Myeloma are looking for participants at sites in Oklahoma.
Cities in Oklahoma
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06465316Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Mercy Hospital Oklahoma City, Oklahoma City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04566328Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
RecruitingPhase 3
All ages · All sexes · Updated Jun 10, 2026 · NCT05561387From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.